AddLife presentation Kristina Willgrd - CEO ADDLIFE AB OPERATIONS - PowerPoint PPT Presentation

ADDLIFE AB OPERATIONS INVESTORS AddLife presentation Kristina Willgård - CEO

ADDLIFE AB OPERATIONS INVESTORS AddLife in brief  A leading independent player in the Nordic Life Science market  Provide equipment, consumables and related services mainly to the healthcare sector in the Nordics  Company heritage dates back to 1906  Listed on Stockholm Stock Exchange 2016 32  29 subsidiaries 3000 2500  Two business areas; Labtech and Medtech 2000  Net sales R12M Q3 2018 1500 245 EURm 1000 500 2017 0 2 2004 2013-14 2014-15 2015-16 2016 2017 Q3 2018

ADDLIFE AB OPERATIONS INVESTORS Geographical markets 32 Population Nordics

ADDLIFE AB OPERATIONS INVESTORS Market Trends Demographics Structural Changes Technology Public Procurement

ADDLIFE AB OPERATIONS INVESTORS Our Market Healthcare & Home care Medtech R&D Industrial analysis Diagnostics Labtech

Labtech Net sales: 145 EURm EBITA: 17 EURm Subsidiaries: 17 Employees: 365

ADDLIFE AB OPERATIONS INVESTORS LABTECH MEDTECH Medtech Net sales: 100 EURm EBITA: 9 EURm Subsidiaries: 13 Employees: 225

ADDLIFE AB OPERATIONS INVESTORS Decentralized organization with entrepreneurial business acumen Flexibility Resources ”Small scale Personality Network business – large scale wise” Effectiveness Sustainability Combine the small With the large company’s… company’s…

AddLife Academy 750 • AddLife Vision and Corporate Philsophy • Sales and Business • Service delivery • Leadership • Marketing & Finance

ADDLIFE AB OPERATIONS INVESTORS Financial goals Profit growth Long term 15 percent yearly Profitability > 45 percent EBITA/WC Dividend 30-50 percent of profit after tax

ADDLIFE AB OPERATIONS INVESTORS Q3 2018 Figures and facts

ADDLIFE AB OPERATIONS INVESTORS Q3 ”Continued growth” Q3  Net Sales SEK 578m (517), +12%, organic 4%  EBITA SEK 51m (44) +16%  EBITA-margin 8.8% (8.5) R12 Months Net Sales SEK 2,465 (2,276) +8%  EBITA SEK 250 (231) +8%  EBITA-margin 10.1% (10.1)  7

ADDLIFE AB OPERATIONS INVESTORS Balance sheet 12

ADDLIFE AB OPERATIONS INVESTORS Our strategies 1 Market leading positions 2 Operating mobility 3 Acquisitions

Aquisitions • Profitable companies with positive development • New markets, segments, solutions or services • Complement to existing offer • Trading companies and companies with nisched own branded products • Strong management

ADDLIFE AB OPERATIONS INVESTORS Yesterday we announced the acquisition of Biomedica  A step beyond the Nordic region  Great business-related similarities  60% Labtech and 40% is Medtech  Company heritage dates back to 1978  HQ in Vienna, Austria 64 EURm 32  12 subsidiaries in the CEE region 70 64  Net sales 2017/2018 60 50 43 40 30 25 20 10 5 0,5 0 2017 2 1978 1988 1998 2008 2018

ADDLIFE AB OPERATIONS INVESTORS Population Nordics A game changer! 32 Population CEE 134 Net sales approx 3,115 MSEK with EBITA approx 294 MSEK

ADDLIFE AB OPERATIONS INVESTORS New share issues • Issue in kind of 100 MSEK to the sellers of Biomedica • Preferential rights issue for AddLife´s existing shareholders of 500 MSEK  The purpose of the rights issue is to raise capital to continue to pursue AddLife’s growth strategy and to carry out more strategic acquisitions.

ADDLIFE AB OPERATIONS INVESTORS Share development since listing

ADDLIFE AB OPERATIONS INVESTORS Q & A